Who to follow: HealthTech executives
DG
Doug Godshall
Chairman and CEO · Galvanize Therapeutics
Professional source · Company profile
MedTech & Devices
Why follow Doug
Doug Godshall is Chairman and CEO of Galvanize Therapeutics, which closed a $130 million Series D in November 2026.
Writes about
Galvanize Therapeutics